Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2CNS 1

Conditions

Breast Neoplasms 60Brain Neoplasms 4Meningeal Carcinomatosis 3Meningeal Neoplasms 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Ovarian Neoplasms 1Neutropenia 1Neoplasms 1Neoplasm Metastasis 1Inflammatory Breast Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Breast Cancer Organoids 1Breast Cancer Female 1

Interventions

Capecitabine 3tucatinib 2Trastuzumab 2Methotrexate 2patritumab deruxtecan 1paclitaxel-Angiopep-2 conjugate 1eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Meningeal Neoplasms × Methotrexate × Breast × Clear all
NCT02422641 2026-06-01

Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Wake Forest University Health Sciences

Phase 2 Recruiting
16 enrolled
Breast

Breast Neoplasms, Meningeal Neoplasms

NCT03613181 2023-04-24

ANGLeD

Angiochem Inc

Phase 3 Unknown
150 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡